Allogeneic hematopoietic cell transplant for acute. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Hematopoietic Stem Cells Allografts T-Lymphocytes Transplants Hematopoietic System Bone Marrow Cells CD8-Positive T-Lymphocytes CD4-Positive T-Lymphocytes Cells, Cultured Bone Marrow Fetal Blood Blood Cells Antilymphocyte Serum

Organisms4

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Cytomegalovirus

Diseases24

Graft vs Host Disease Hematologic Neoplasms Cytomegalovirus Infections Leukemia Recurrence Leukemia, Myeloid, Acute Myelodysplastic Syndromes Hematologic Diseases Acute Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Mycoses Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoproliferative Disorders Lymphoma Chronic Disease Lymphoma, Non-Hodgkin Opportunistic Infections Anemia, Aplastic Aspergillosis Hepatic Veno-Occlusive Disease Roseolovirus Infections Multiple Myeloma Leukemia, Myeloid Postoperative Complications

Chemicals and Drugs18

Busulfan Immunosuppressive Agents Myeloablative Agonists Antiviral Agents Vidarabine Minor Histocompatibility Antigens HLA Antigens Cyclosporine Tacrolimus Mycophenolic Acid Cyclophosphamide Antigens, CD34 Complementarity Determining Regions Antineoplastic Agents Isoantigens Ganciclovir Interleukin-3 Antilymphocyte Serum

Analytical, Diagnostic and Therapeutic Techniques and Equipment42

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Treatment Outcome Retrospective Studies Whole-Body Irradiation Bone Marrow Transplantation Histocompatibility Testing Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Survival Analysis Cord Blood Stem Cell Transplantation Donor Selection Survival Rate Stem Cell Transplantation Remission Induction Transplantation Kidney Transplantation Disease-Free Survival Immunosuppression Follow-Up Studies Risk Factors Combined Modality Therapy Lymphocyte Depletion Salvage Therapy Prognosis Cohort Studies Heart Transplantation Incidence Prospective Studies Antineoplastic Combined Chemotherapy Protocols Flow Cytometry Transplantation, Isogeneic Lymphocyte Culture Test, Mixed Fetal Tissue Transplantation Lung Transplantation Hematopoietic Stem Cell Mobilization Multivariate Analysis Leukocyte Transfusion Skin Transplantation Colony-Forming Units Assay Cell Transplantation

Psychiatry and Psychology1

Phenomena and Processes12

Graft vs Tumor Effect Graft vs Leukemia Effect Graft Survival Chimerism Histocompatibility Graft Rejection Time Factors Hematopoiesis Immunocompromised Host Complementarity Determining Regions Transplantation Immunology Cell Differentiation

Anthropology, Education, Sociology and Social Phenomena1

Information Science2

Survival Rate Incidence

Named Groups4

Tissue Donors Unrelated Donors Siblings Living Donors

Health Care13

Treatment Outcome Retrospective Studies Survival Analysis Donor Selection Survival Rate Disease-Free Survival Follow-Up Studies Risk Factors Cohort Studies Age Factors Incidence Prospective Studies Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Graft vs Host Disease Transplantation Conditioning Hematologic Neoplasms Busulfan Tissue Donors Immunosuppressive Agents Cytomegalovirus Infections Treatment Outcome Myeloablative Agonists Retrospective Studies Graft vs Tumor Effect Antiviral Agents Whole-Body Irradiation Bone Marrow Transplantation Graft vs Leukemia Effect Unrelated Donors Histocompatibility Testing Graft Survival Leukemia Recurrence Hematopoietic Stem Cells Transplantation, Autologous Leukemia, Myeloid, Acute Vidarabine Transplantation Chimera Chimerism Histocompatibility Minor Histocompatibility Antigens Peripheral Blood Stem Cell Transplantation Survival Analysis Siblings Graft Rejection Cord Blood Stem Cell Transplantation HLA Antigens Myelodysplastic Syndromes Hematologic Diseases Donor Selection Survival Rate Allografts Stem Cell Transplantation Remission Induction Transplantation Cyclosporine Acute Disease T-Lymphocytes Kidney Transplantation Time Factors Precursor Cell Lymphoblastic Leukemia-Lymphoma Mycoses Disease-Free Survival Leukemia, Myelogenous, Chronic, BCR-ABL Positive Immunosuppression Transplants Follow-Up Studies Hematopoiesis Tacrolimus Lymphoproliferative Disorders Risk Factors Combined Modality Therapy Hematopoietic System Living Donors Bone Marrow Cells Mycophenolic Acid Mice, Inbred C57BL Immunocompromised Host Lymphocyte Depletion Lymphoma Chronic Disease Lymphoma, Non-Hodgkin Salvage Therapy Cyclophosphamide Antigens, CD34 Complementarity Determining Regions Antineoplastic Agents Prognosis Mice, Inbred BALB C Cohort Studies Transplantation Immunology Opportunistic Infections Heart Transplantation Cytomegalovirus CD8-Positive T-Lymphocytes Age Factors Incidence Prospective Studies Antineoplastic Combined Chemotherapy Protocols CD4-Positive T-Lymphocytes Anemia, Aplastic Isoantigens Cell Differentiation Flow Cytometry Aspergillosis Cells, Cultured Bone Marrow Transplantation, Isogeneic Hepatic Veno-Occlusive Disease Roseolovirus Infections Lymphocyte Culture Test, Mixed

No FAQ available that match "allogeneic hematopoietic cell transplant for acute"